Christine Blank
Contributing Editor Christine Blank is a freelance writer based in Florida.
FDA approves expansion of Avastin in ovarian cancer
FDA recently approved bevacizumab (Avastin, Genentech) for patients with platinum-sensitive recurrent epithelial ovarian (psOC), fallopian tube or primary peritoneal cancer.
US drug spending predicted to drop
US drug spending predicted to drop
The US growth rate for spending on medicines is expected to fall in 2016 and beyond, according to new research.
Analyst: CVS’ OptumRx deal amps up competition
Last month, OptumRx and CVS Pharmacy announced that they are partnering to provide more convenient choices and lower costs for patients.
Are states going too far with painkiller script limits?
Arizona has become the latest state to limit opioid prescriptions—a trend that has some healthcare providers and experts concerned.
New COPD guidelines tout bronchodilators and antibiotics
Use inhaled corticosteroids sparingly and only in these circumstances in patients with COPD. Details here.
Study finds hike in pneumonia for COPD patients receiving corticosteroids
Comorbid CVD is an independent risk factor for CAP in patients with COPD. And inhaled steroids may increase CAP risk.
New drug indication could net more than $1 billion
FDA’s approval of a new indication for empagliflozin (Jardiance, Eli Lilly and Boehringer Ingelheim) could net the pharmaceutical manufacturers more than $1 billion.
Breast cancer biosimilar shows equivalency to brand
Breast cancer biosimilar shows equivalency to brand
Two new major studies on a biosimilar to trastuzumab (Herceptin, Genentech) to treat HER2-positive metastatic breast cancer and HER2-positive gastric cancer demonstrated equivalency.
Human trials of Zika vaccine underway
The Army has made significant progress on the Zika vaccine in just 10 months. Details here.
HIV vaccine could be nail in coffin for disease
A clinical study, recently begun in South Africa, is testing whether an experimental vaccine regimen safely prevents HIV infection.